BIOMAT Database Logo BIOMAT Database Logo

Anti-tumor necrosis factor alpha serum prolongs heart allograft survival in rats. 1991

M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Laboratory for Experimental Surgery, Erasmus University, Rotterdam, The Netherlands.

UI MeSH Term Description Entries
D007116 Immunization, Passive Transfer of immunity from immunized to non-immune host by administration of serum antibodies, or transplantation of lymphocytes (ADOPTIVE TRANSFER). Convalescent Plasma Therapy,Immunoglobulin Therapy,Immunotherapy, Passive,Normal Serum Globulin Therapy,Passive Antibody Transfer,Passive Transfer of Immunity,Serotherapy,Passive Immunotherapy,Therapy, Immunoglobulin,Antibody Transfer, Passive,Passive Immunization,Therapy, Convalescent Plasma,Transfer, Passive Antibody
D008297 Male Males
D011914 Rats, Inbred BN An inbred strain of rat that is widely used in a variety of research areas such as the study of ASTHMA; CARCINOGENESIS; AGING; and LEUKEMIA. Rats, Inbred Brown Norway,Rats, BN,BN Rat,BN Rat, Inbred,BN Rats,BN Rats, Inbred,Inbred BN Rat,Inbred BN Rats,Rat, BN,Rat, Inbred BN
D011919 Rats, Inbred Strains Genetically identical individuals developed from brother and sister matings which have been carried out for twenty or more generations or by parent x offspring matings carried out with certain restrictions. This also includes animals with a long history of closed colony breeding. August Rats,Inbred Rat Strains,Inbred Strain of Rat,Inbred Strain of Rats,Inbred Strains of Rats,Rat, Inbred Strain,August Rat,Inbred Rat Strain,Inbred Strain Rat,Inbred Strain Rats,Inbred Strains Rat,Inbred Strains Rats,Rat Inbred Strain,Rat Inbred Strains,Rat Strain, Inbred,Rat Strains, Inbred,Rat, August,Rat, Inbred Strains,Rats Inbred Strain,Rats Inbred Strains,Rats, August,Rats, Inbred Strain,Strain Rat, Inbred,Strain Rats, Inbred,Strain, Inbred Rat,Strains, Inbred Rat
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D006085 Graft Survival The survival of a graft in a host, the factors responsible for the survival and the changes occurring within the graft during growth in the host. Graft Survivals,Survival, Graft,Survivals, Graft
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D014184 Transplantation, Homologous Transplantation between individuals of the same species. Usually refers to genetically disparate individuals in contradistinction to isogeneic transplantation for genetically identical individuals. Transplantation, Allogeneic,Allogeneic Grafting,Allogeneic Transplantation,Allografting,Homografting,Homologous Transplantation,Grafting, Allogeneic
D014409 Tumor Necrosis Factor-alpha Serum glycoprotein produced by activated MACROPHAGES and other mammalian MONONUCLEAR LEUKOCYTES. It has necrotizing activity against tumor cell lines and increases ability to reject tumor transplants. Also known as TNF-alpha, it is only 30% homologous to TNF-beta (LYMPHOTOXIN), but they share TNF RECEPTORS. Cachectin,TNF-alpha,Tumor Necrosis Factor Ligand Superfamily Member 2,Cachectin-Tumor Necrosis Factor,TNF Superfamily, Member 2,TNFalpha,Tumor Necrosis Factor,Cachectin Tumor Necrosis Factor,Tumor Necrosis Factor alpha
D016027 Heart Transplantation The transference of a heart from one human or animal to another. Cardiac Transplantation,Grafting, Heart,Transplantation, Cardiac,Transplantation, Heart,Cardiac Transplantations,Graftings, Heart,Heart Grafting,Heart Graftings,Heart Transplantations,Transplantations, Cardiac,Transplantations, Heart

Related Publications

M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Anti-tumor necrosis factor antibody enhances allograft survival in rats.
April 1990, The Journal of surgical research,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
The role of tumor necrosis factor in allograft rejection. III. Evidence that anti-TNF antibody therapy prolongs allograft survival in rats with acute rejection.
January 1991, Transplantation,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Behavioral conditioning prolongs heart allograft survival in rats.
December 1991, Brain, behavior, and immunity,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Behavioral conditioning prolongs heart allograft survival in rats.
August 1998, Transplantation proceedings,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Anti-TCR Vbeta-specific DNA vaccination prolongs heart allograft survival in adult rats.
September 2000, European journal of immunology,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
The role of tumor necrosis factor in allograft rejection. II. Evidence that antibody therapy against tumor necrosis factor-alpha and lymphotoxin enhances cardiac allograft survival in rats.
August 1990, Transplantation,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Raised serum levels of cachectin/tumor necrosis factor alpha in renal allograft rejection.
October 1987, The Journal of experimental medicine,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Treatment with monoclonal anti-IL2 antibody prolongs cardiac allograft survival in rats.
October 1987, Transplantation proceedings,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
T-cell vaccination prolongs heart but not islet allograft survival in rats.
December 1995, Transplantation proceedings,
M Scheringa, and R W de Bruin, and H Jeekel, and R L Marquet
Tumor necrosis factor-alpha in cardiovascular biology and the potential role for anti-tumor necrosis factor-alpha therapy in heart disease.
January 2002, Pharmacology & therapeutics,
Copied contents to your clipboard!